A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer

Clinical trial NCT02737787 · COMPLETED

Trial details

NCT number: NCT02737787
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Primary Peritoneal Cancer Recurrent Ovarian Cancer

Start date: 2016-04-01
Primary completion: 2023-04-06
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.